TransMedics Group Inc is trading 4.6% up at $76.57 today, rebounding from yesterday’s 3.4% drop. Stifel raised its price target for TMDX to $80 from $75 on Thursday (June 18, 2026), citing strong flight data and expectations for a solid Q2 2026 revenue beat of $195 million. Broader market indices are also trading modestly higher, contributing to a general risk-on sentiment.